Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ESRT
NYSE:ESRTOffice REITs

A Look At Empire State Realty Trust’s Valuation After Earnings, New Leases And Buybacks

Why Empire State Realty Trust is back on investors’ radar Empire State Realty Trust (ESRT) has moved back into focus after fourth quarter 2025 results showed higher quarterly revenue and net income year over year, alongside fresh leasing wins with major tenants. For the fourth quarter, ESRT reported sales of US$159.72 million and revenue of US$199.22 million, compared with US$155.13 million and US$197.6 million a year earlier. Net income came in at US$20.73 million versus US$12.22 million,...
NasdaqGM:FLGT
NasdaqGM:FLGTHealthcare

Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress

Fulgent Genetics (FLGT) is back on investors’ radar after its latest update, with 2025 earnings showing US$322.67 million in sales, a wider net loss, and fresh 2026 revenue guidance of about US$350 million. See our latest analysis for Fulgent Genetics. The share price reaction has been sharp, with a 1 day share price return of a 38.09% decline and a year to date share price return of a 40.09% decline, even though the 1 year total shareholder return is roughly flat. This suggests recent...
TSX:PSK
TSX:PSKOil and Gas

How Investors May Respond To PrairieSky Royalty (TSX:PSK) CEO’s CA$152k Insider Share Purchase

On February 26, 2026, PrairieSky Royalty CEO Andrew Phillips acquired 5,000 common shares on a direct ownership basis at a price of CA$30.355, signaling a clear personal capital commitment to the company. This insider purchase stands out because it reflects senior management’s willingness to increase exposure to PrairieSky’s royalty-based oil and gas model using their own funds. Next, we’ll examine how the CEO’s recent insider purchase could influence PrairieSky Royalty’s existing investment...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Did Strong 2025 Results and Capital Returns Just Shift Safety Insurance Group's (SAFT) Investment Narrative?

Safety Insurance Group, Inc. reported past full-year 2025 results, with revenue of US$1,263.73 million and net income of US$99.26 million, alongside fourth-quarter net income of US$20.1 million on revenue of US$319.3 million. The company paired these stronger earnings with shareholder-focused actions, including repurchasing US$20 million of stock in the fourth quarter and approving a US$0.92 per-share quarterly dividend payable in March 2026. We’ll now examine how the combination of improved...
ASX:A1M
ASX:A1MMetals and Mining

AIC Mines (ASX:A1M) Is Up 17.9% After Higher Half-Year Profit And EPS Growth - What's Changed

AIC Mines Limited recently reported its half-year results for the period ended December 31, 2025, with sales of A$110.59 million and net income of A$17.35 million, both higher than the prior year. The company also lifted basic earnings per share from continuing operations to A$0.0223, highlighting improved profitability on a per-share basis. We’ll now examine how this earnings and sales growth shapes AIC Mines’ investment narrative and what it might mean for investors. Uncover the next big...
NYSE:DELL
NYSE:DELLTech

US Stock Market Today S&P 500 Futures Slide On Inflation And Geopolitical Jitters

The Morning Bull - US Market Morning Update Monday, Mar, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 futures down about 1.3% and Nasdaq futures off roughly 1.7%, as investors react to a mix of higher costs and geopolitical tension. Government bond yields in Italy, Germany and the UK are higher, which means borrowing is getting more expensive just as Middle East tensions keep energy prices and inflation worries alive. At the same time, factory scorecards such...
OM:BIOG B
OM:BIOG BBiotechs

Is BioGaia (OM:BIOG B) Quietly Redefining Its Global Strategy Through The Ewopharma Deal?

Earlier in 2026, BioGaia announced it had renewed and broadened its distribution agreement with regional partner Ewopharma, expanding access to its probiotic portfolio across more than 15 European countries. This enlarged footprint with a long-standing regional distributor could be important for BioGaia’s efforts to scale its international presence through partnership-led growth. We’ll now explore how the expanded Ewopharma distribution agreement may influence BioGaia’s investment narrative...
SEHK:2778
SEHK:2778Office REITs

A Look At Champion REIT (SEHK:2778) Valuation After Earnings Signal Resilience In A Tough Office Market

Champion Real Estate Investment Trust (SEHK:2778) has drawn investor attention after its 2025 earnings call, where management reported lower rental and net property income but stable occupancy, proactive refinancing, and efforts to refresh the tenant mix. See our latest analysis for Champion Real Estate Investment Trust. The earnings announcement on 25 February appears to have coincided with stronger interest in the units, with a 21.74% 90 day share price return and a 67.17% 1 year total...
NYSE:HOUS
NYSE:HOUSReal Estate

Anywhere Real Estate (HOUS) Is Up 24.6% After Narrowing Annual Net Loss On Higher Revenue - What's Changed

Anywhere Real Estate Inc. has released its full-year 2025 results, reporting revenue of US$5,960 million compared with US$5,692 million in 2024, and a net loss of US$90 million versus US$128 million previously. The combination of higher revenue and a smaller net loss points to operational progress that investors may see as a sign of improving financial health, even though the business remains loss-making. We’ll now examine how this revenue growth and reduced net loss might reshape Anywhere...
BME:A3M
BME:A3MMedia

Assessing Atresmedia (BME:A3M) Valuation After Advertising Weakness And Expansion Beyond Traditional TV

Why Atresmedia’s latest results matter for shareholders Atresmedia Corporación de Medios de Comunicación (BME:A3M) has reported its 2025 results, highlighting revenue pressure from a weaker television advertising market, as well as record shareholder returns and a push into new media formats. See our latest analysis for Atresmedia Corporación de Medios de Comunicación. Atresmedia’s latest update comes after a mixed year in the market, with a 1-day share price return of 2.17% and a year to...
XTRA:HEI
XTRA:HEIBasic Materials

Heidelberg Materials (XTRA:HEI) Margin Improvement Reinforces Bullish Profitability Narratives

Heidelberg Materials FY 2025 earnings snapshot Heidelberg Materials (XTRA:HEI) has posted its FY 2025 numbers with second half revenue of €11.1b and basic EPS of €7.29, while trailing twelve month revenue sits at €21.5b and EPS at €11.17, alongside 13.7% earnings growth over the past year. The company has seen revenue move from €21.3b to €21.5b on a trailing basis, as EPS climbed from €9.67 to €11.17 over the same period. Earnings growth has outpaced revenue and net profit margin stands at...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Does Day One Biopharmaceuticals (DAWN) Share Price Reflect Its Oncology Pipeline Prospects?

If you are wondering whether Day One Biopharmaceuticals' current share price lines up with its underlying worth, you are not alone. The stock most recently closed at US$10.60, with a 7 day return of 10% decline, a 30 day return of 5% decline, gains of 19.8% year to date and 17% over the past year, while the 3 year return sits at 43.4% decline. Recent news around Day One has largely focused on its development stage oncology pipeline and ongoing progress in clinical programs, which can...
ASX:HZN
ASX:HZNOil and Gas

Assessing Horizon Oil (ASX:HZN) Valuation After Softer Half Year Earnings And Dividend Declaration

Horizon Oil’s latest earnings and dividend decision Recent interest in Horizon Oil (ASX:HZN) stems from its half year 2025 results, which showed lower sales and net income, alongside a declared interim dividend and an upcoming earnings call. See our latest analysis for Horizon Oil. Horizon Oil’s recent earnings release and confirmed interim dividend have come alongside firm share price momentum, with a 90 day share price return of 23.08% and a 1 year total shareholder return of 39.22% from a...
SGX:C09
SGX:C09Real Estate

Assessing City Developments (SGX:C09) Valuation After Strong 2025 Earnings And New Dividend Announcement

Earnings and dividend move City Developments into focus City Developments (SGX:C09) has drawn fresh attention after releasing its full year 2025 results, alongside declaring an annual dividend of S$0.2500 per share payable in May 2026. See our latest analysis for City Developments. The strong full year 2025 results and new S$0.2500 dividend have arrived alongside a 36.39% 90 day share price return and a 1 year total shareholder return of 95.83%. This suggests momentum has been building from...
OB:AKRBP
OB:AKRBPOil and Gas

Aker BP’s AI‑Enabled MMO Alliance With Aker Solutions Might Change The Case For Investing In Aker BP (OB:AKRBP)

In February 2026, Aker Solutions announced it had secured a five-year Maintenance, Modification and Operation services agreement from Aker BP, covering all Aker BP-operated assets on the Norwegian continental shelf from 1 March 2026, with options for two additional four-year extensions. This next-generation MMO alliance stands out for its use of fully integrated teams, data-driven and AI-supported workflows, and performance‑linked commercial incentives to modernise Aker BP’s facilities and...
ASX:APZ
ASX:APZREITs

Aspen Group (ASX:APZ) Is Up 8.1% After Lifting Revenue And Clarifying 2026 Dividend Guidance – Has The Bull Case Changed?

In February 2026, Aspen Group reported half-year results to 31 December 2025, with revenue rising to A$69.97 million and net income to A$35.94 million, and issued dividend guidance of 11.0 cents for fiscal 2026. The modest uplift in earnings per share, alongside clearer dividend guidance, offers investors a more defined picture of Aspen Group’s capital returns profile. We’ll now explore how Aspen Group’s increased revenue and clarified 2026 dividend guidance shape the company’s broader...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Is Kaiser Aluminum (KALU) Still Attractive After A 90% One-Year Share Price Surge?

If you are wondering whether Kaiser Aluminum's current share price lines up with its underlying worth, this article walks through the key signals you will want to weigh. The stock last closed at US$130.14, with returns of 0.9% over 7 days, 6.1% over 30 days, 8.2% year to date, 90.5% over 1 year, 74.0% over 3 years, and 36.6% over 5 years. This performance sets an important backdrop for any value check. Recent coverage around Kaiser Aluminum has focused on how investors view its role within...
BIT:SPM
BIT:SPMEnergy Services

Is It Too Late To Consider Saipem (BIT:SPM) After Its Strong Recent Share Price Run?

If you are wondering whether Saipem is still attractively priced after its recent run, this article will walk through what the current share price might be implying about value. The stock has been strong recently, with returns of 4.3% over 7 days, 14.9% over 30 days, 42.8% year to date, 75.4% over 1 year and 157.4% over 3 years, while the 5 year return stands at a 34.7% decline. These moves sit against a backdrop of ongoing interest in energy services and infrastructure, as investors...
OB:NORSE
OB:NORSEAirlines

Norse Atlantic (OB:NORSE) Load Factors Above 95% Challenge Bearish Profitability Narratives

Norse Atlantic (OB:NORSE) has just posted fourth quarter 2025 revenue of US$156.3 million with a basic EPS loss of US$0.63, while on a trailing twelve month basis revenue sits at US$734.0 million and basic EPS at a loss of US$0.42. Over the past year, the company has seen revenue move from US$588.1 million in the trailing twelve months to Q4 2024 to US$734.0 million in the latest trailing period, with basic EPS narrowing from a loss of US$1.05 to a loss of US$0.42. For investors, the latest...
NYSE:PRM
NYSE:PRMChemicals

Perimeter Solutions Balances Sauget Setbacks With Acquisition And Contract Shift

Perimeter Solutions (NYSE:PRM) is dealing with operational and safety issues at its Sauget P2S5 facility that have led to reduced production and ongoing litigation as it seeks to take control of the site. The company has recently closed a sizeable acquisition while shifting more of its portfolio toward fixed and recurring contracts to support more consistent earnings. These developments affect a key production asset and the structure of Perimeter Solutions' revenue, with potential...
SEHK:14
SEHK:14Real Estate

A Look At Hysan Development’s (SEHK:14) Valuation After Full Year 2025 Results And Redevelopment Updates

Hysan Development (SEHK:14) has just released its full year 2025 results, pairing earnings and sales figures with a second interim dividend and new progress updates on its Lee Gardens redevelopment and capital recycling plans. See our latest analysis for Hysan Development. At a share price of HK$21.82, Hysan’s recent moves on earnings, dividends and the Lee Gardens redevelopment sit against a 90 day share price return of 22.72% and a 1 year total shareholder return of 76.77%. This suggests...
TSE:6752
TSE:6752Consumer Durables

Panasonic LUMIX Mic Launch Adds Interest To Valuation And Momentum Story

Panasonic Holdings launched the DMW-DMS1 Digital Shotgun Microphone for its LUMIX camera lineup. The new accessory introduces six selectable directional modes, 32-bit float recording and wind-noise suppression. The microphone connects without cables to compatible LUMIX cameras, aiming to offer more flexible and reliable audio capture for creators. For investors watching Panasonic Holdings (TSE:6752), this launch adds a fresh piece to the company’s imaging ecosystem at a time when demand for...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax’s Third FDA Win Accelerates Shift To Multi Product Revenues

Syndax Pharmaceuticals secured its third FDA approval within a year, following the launches of Revuforj and Niktimvo. The company is rapidly shifting into a commercial-stage model with revenues now coming from multiple newly approved therapies. Pivotal clinical trials are in progress that could support label expansions and additional indications. Syndax Pharmaceuticals, NasdaqGS:SNDX, is moving from a pure R&D story to an active commercial player, supported by three FDA approved therapies...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Flywire Taps Payments Veteran As CTO To Drive AI First Growth

Flywire appointed Patrick Blanc as Chief Technology Officer as part of a leadership realignment focused on AI driven product development. Blanc brings payments technology experience from senior roles at Ingenico, Visa, and PayPal. David King moved into the role of Chief Product Officer and Co President of Global Education to support Flywire's product and sector focus. For investors tracking NasdaqGS:FLYW, this leadership reshuffle comes with the stock recently closing at $12.31 and showing...